Page 1 of Clinical Trials for regional transitional cell cancer of the renal pelvis and ureter, 49 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
Last Updated: July 23, 2008
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter
2
Completed
Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
Last Updated: January 26, 2010
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
3
Completed
Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract
Last Updated: May 18, 2010
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter
4
Completed
Bortezomib in Treating Patients With Advanced Transitional Cell Carcinoma of the Urothelium
Last Updated: April 6, 2011
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
5
Completed
Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
Last Updated: May 29, 2009
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
6
Terminated
S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
Last Updated: August 24, 2011
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
7
Completed
Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium
Last Updated: September 18, 2009
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter
8
Active, not recruiting
S0219, Combination Chemotherapy Followed By Observation or Surgery in Treating Patients With Stage II or Stage III Cancer of the Urothelium
Last Updated: July 21, 2011
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
9
Recruiting
E7389 in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Last Updated: February 16, 2012
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
10
Active, not recruiting
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
Last Updated: July 23, 2008
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
11
Completed
VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium
Last Updated: October 11, 2010
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
12
Completed
Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer
Last Updated: July 23, 2008
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
13
Completed
Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium
Last Updated: January 26, 2010
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
14
Active, not recruiting
Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract
Last Updated: February 6, 2009
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
15
Completed
Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer
Last Updated: May 14, 2011
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter
16
Active, not recruiting
S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy
Last Updated: July 21, 2011
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
17
Recruiting
Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium
Last Updated: March 27, 2010
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
18
Completed
Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer
Last Updated: December 13, 2009
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter
19
Recruiting
Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium
Last Updated: March 30, 2012
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
20
Active, not recruiting
Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium
Last Updated: November 2, 2010
Condition(s): Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=regional+transitional+cell+cancer+of+the+renal+pelvis+and+ureter

Page 1 of Clinical Trials for regional transitional cell cancer of the renal pelvis and ureter, 49 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About